SUTRO BIOPHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2019 to Q3 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Sutro Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2019 to Q3 2024.
- Sutro Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 82M shares, a 35.4% increase year-over-year.
- Sutro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 60.2M shares, a 18.6% increase from 2022.
- Sutro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 50.7M shares, a 10% increase from 2021.
- Sutro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 46.1M shares, a 41.6% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)